News

News

Covid-19 threatens gains against HIV

07 Jul 2020

According to a study by the United Nations Programme on HIV/ADS (UNAIDS) 42 500 more lives than usual would be lost to HIV/AIDS in the next year. This is the figure projected if half the people in SA on treatment were unable to get their medication for six months; a figure that rises to 112 000 excess deaths should antiretroviral supplies collapse completely.


[READ MORE]

Condolences to the family of Dr Dr Nthabi Rankhethoa (ENT)

07 Jul 2020

In a media statement, the Ear nose and Throat Society (ENT) informed its members of the passing on of one of its respected colleagues, Dr Nthabi Rankhethoa on July 3.


[READ MORE]

Hospital groups gear up for Covid-19 with under-pressure balance sheets

07 Jul 2020

As the infection rate continues to climb and gets closer to the 200 000 mark, private hospital groups Netcare, Life Healthcare and Mediclinic have had to shift their focus to dealing with the pandemic while their regular patients choose to stay away, reported Fin24 (6 July 2020).


[READ MORE]

TB meds side-effects crisis

07 Jul 2020

According to a study, published by the Human Sciences Research Council (HSRC), the inadequate

reporting of the side-effects of drug-resistant TB (DR-TB) were one of main reasons for patients defaulting on medication. 
[READ MORE]

Diabetics moved to front of Covid-19 test queue as deaths rocket

03 Jul 2020

The Western Cape Health Department is implementing a new model of care diabetics to admitted to hospital with Covid-19. The mortality rate among those admitted with diabetes and Covid-19 was 45%, almost twice the average of 25%.


[READ MORE]

Cipla to bring remdesivir to SA

03 Jul 2020

Indian drug manufacturer Cipla announced that it will soon provide SA with its generic version of the coronavirus drug remdesivir. An initial batch of 35 000 vials should arrive in the week of July 20.This is the firstdrug to have been approved by US authorities to treat Covid-19.


[READ MORE]

Growing evidence of Covid-diabetes links

03 Jul 2020

According to an article in the latest SA Medical Journal international experts in diabetes say they

suspect the virus might trigger the disease in some C-19 survivors.

Four SA researchers, Agnes Erzse, Heather Fraser and Karen Hoffman, from the SA Medical Research Council (SAMRC) and Johannesburg’s Wits Centre for Health Economics and Decision Science, and Naomi Levitt, from the University of Cape Town (UCT), said the C-19 emergency should be used as an opportunity to intensify the war on diabetes.


[READ MORE]

Beware armchair analysis of Covid-19 figures

02 Jul 2020

“The problem with the numbers is they do not allow you to make any sort of extrapolation as there are too many moving parts,” wrote - Tamar Kahn in Business Day (2 July 2020).


[READ MORE]

C-19 vaccine should be available within a year

02 Jul 2020
Dr Larry Corey, one of the world’s most well-known biomedical researchers, told a webinar audience of over 1 500 healthcare workers that COVID-19 was ‘more of a discernible virus than HIV.’ The recent webinar was hosted by Discovery Health and Medical Brief, in conjunction with the Desmond Tutu HIV Foundation, the SA Medical Association, the SA Private Practitioners Forum and the Unity Forum for Family Practitioners.

[READ MORE]

South Africans are hardest hit by the coronavirus –

01 Jul 2020
Business Tech reported on June 30, that by middle June medical schemes had admitted 2 155 patients diagnosed with C-19 patients to hospitals. Those admitted, stayed in hospital for an average of between 8 to 12 days in an Intensive Care Unit (ICU). Over 50% of the patients who died had two or more co-morbidities, and the vast majority of these were hypertension,

[READ MORE]

Local biotech firm plans to plug Covid-19 test kit shortage

30 Jun 2020

A local biotechnology firm, CapeBio Technology, is stepping up to try plug the shortfall in SA’s testing capacity.

CapeBio Technologies plans to roll out 5 000 test kits a day from the end of July, with support from the government. The kits will produce results within two hours, down from the three to four hours taken by the imported kits available in the market at present, reported Reuters.


[READ MORE]

Gilead to charge governments $2 340 per patient for remdesivir

30 Jun 2020
The pharmaceutical company Gilead Sciences has priced its Covid-19 drug candidate remdesivir at $2 340 for a fiveday treatment in the US and some other developed countries, potentially reflecting looming competition from a cheap steroid, reported Reuters
[READ MORE]

Covid-19 drives private health sector to the brink

29 Jun 2020

A new healthcare framework, developed by Prof Alex van den Heever, was proposed to resuscitate the country’s ailing private healthcare sector, which has been dealt a huge blow by the outbreak of theCovid-19 coronavirus, reported City Press (28 June 2020).


[READ MORE]

Row over medical scheme merger

29 Jun 2020

The Council of Medical Schemes (CMS) has stepped in to halt the proposed merger of black-owned Sizwe Medical Aid and Hosmed Medical Scheme, in what may be a serious blow to the much-needed transformation of the sector,” reported Mail & Guardian (26 June 2020).


[READ MORE]

Prof Lungile Pepeta the new chairperson of CMS Council

29 Jun 2020

On June 25, Health Minister, Zweli Mkhize, appointed Professor Lungile Pepeta as the new Chairperson of the Council for Medical Schemes (CMS), the regulator of the medical schemes industry. This appointment is effective from 18 June 2020 to the end of November 2020.


[READ MORE]
Page 1 of 2 Next > >>